TECH Stock Price, Chart, Stats & News

Bio-Techne Corporation
Save
TECH chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 65.22% |
Operating margin | 9.62% |
Pretax margin | 9.39% |
Net margin | 6.67% |
Effective tax rate | 28.97% |
ROA | 3.21% |
ROE | 4.10% |
D/E | 0.17x |
Interest coverage ratio | 12.59x |
TECH valuation
P/E | 154.58x |
P/S | 6.56x |
P/B | 3.95x |
P/CF | 31.85x |
P/FCF | 35.74x |
P/OCF | 31.85x |
PEG | 24.47x |
EV multiple | 34.30x |
About
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.
Similar securities
Based on sector and market capitalization
Report issue











